In conclusion, this study showed that high expression levels of ADAM8, ADAM9 and ADAM15 are interesting biomarkers of prognostic relevance in MM, that are linked to a high-risk status and disease progression and influence several important survival and proliferation signaling pathways. The gene discussed is ADAM9; the disease is Miyoshi myopathy.